Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Luciano G Martelotto
Affiliation
Monash University
ORCID
Career Start Year
2000
Papers
66
H Index
32
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36712845
Editorial: RNA-chromatin interactions: Biology, mechanism, disease and therapeutics.
Front Genet
2023
37845394
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.
Oncogene
2023
37601968
<i>Fancm</i> has dual roles in the limiting of meiotic crossovers and germ cell maintenance in mammals.
Cell Genom
2023
36624099
Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.
Nat Commun
2023
35235413
Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.
JCO Precis Oncol
2022
35611998
ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo.
Adv Sci (Weinh)
2022
35816165
Isolating Nuclei From Frozen Human Heart Tissue for Single-Nucleus RNA Sequencing.
Curr Protoc
2022
36209820
Paraspeckle subnuclear bodies depend on dynamic heterodimerisation of DBHS RNA-binding proteins via their structured domains.
J Biol Chem
2022
36271074
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.
Nat Commun
2022
36173986
SSNIP-seq: A simple and rapid method for isolation of single-sperm nucleic acid for high-throughput sequencing.
PLoS One
2022
35977494
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cells.
Cell Rep
2022
36318921
Human prefrontal cortex gene regulatory dynamics from gestation to adulthood at single-cell resolution.
Cell
2022
35311997
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.
Cancer Discov
2022
34880496
Non-genetic determinants of malignant clonal fitness at single-cell resolution.
Nature
2022
32946634
Prevalence and potential biological role of TERT amplifications in ALK translocated adenocarcinoma of the lung.
Histopathology
2021
33674358
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival.
Cancer Immunol Res
2021
33608275
SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells.
Sci Adv
2021
33990344
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory.
Cancer Discov
2021
33303574
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma.
Cancer Immunol Res
2021
32794624
Genomic Cytometry and New Modalities for Deep Single-Cell Interrogation.
Cytometry A
2020
32023457
A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability.
Cell Rep
2020
33097816
From whole-mount to single-cell spatial assessment of gene expression in 3D.
Commun Biol
2020
32939092
Reprogramming roadmap reveals route to human induced trophoblast stem cells.
Nature
2020
32654508
Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.
Biotechniques
2020
30617056
Single-Cell Applications of Next-Generation Sequencing.
Cold Spring Harb Perspect Med
2019
31222014
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
Nat Commun
2019
29149504
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
J Pathol
2018
29885057
Genetic instability and recurrent MYC amplification in ALK-translocated NSCLC: a central role of TP53 mutations.
J Pathol
2018
30045976
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.
Sci Transl Med
2018
29739933
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.
Nat Commun
2018
29398263
Expression of Androgen Receptor Splice Variant 7 or 9 in Whole Blood Does Not Predict Response to Androgen-Axis-targeting Agents in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
2018
28714990
An approach to suppress the evolution of resistance in BRAF<sup>V600E</sup>-mutant cancer.
Nat Med
2017
28165479
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples.
Nat Med
2017
28299801
Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.
J Pathol
2017
28188619
Generation of conditional oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing and homology-directed repair.
J Pathol
2017
28187190
Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.
PLoS One
2017
29214215
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast.
NPJ Breast Cancer
2017
28765325
Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer.
Clin Cancer Res
2017
25951887
Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing.
Histopathology
2016
26592504
Uterine adenosarcomas are mesenchymal neoplasms.
J Pathol
2016
26426580
Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland.
Histopathology
2016
26556035
TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
Int J Gynecol Pathol
2016
27913435
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
Cancer Res
2016
27491809
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.
Mod Pathol
2016
26832993
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
J Pathol
2016
26960396
The Genomic Landscape of Male Breast Cancers.
Clin Cancer Res
2016
26011570
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
J Pathol
2015
26095796
Genomic landscape of adenoid cystic carcinoma of the breast.
J Pathol
2015
25855048
MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
Histopathology
2015
25994018
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.
Genome Biol
2015
1 - 50 of 66
Column Actions
Search
Recommended Authors
Rohan Bareja
Case Western Reserve University
Career Start Year
2017
Number of shared co-authors
8
Yari Ciani
University of Trento
Career Start Year
2012
Number of shared co-authors
2
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year
2010
Number of shared co-authors
6
David A Quigley
University of California-San Francisco
Career Start Year
2008
Number of shared co-authors
2
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year
2008
Number of shared co-authors
0
Xinmin Li
University of California los angeles
Career Start Year
2008
Number of shared co-authors
1
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year
2007
Number of shared co-authors
2
Ritu Roy
University of California San Francisco.
Career Start Year
2007
Number of shared co-authors
1
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year
2006
Number of shared co-authors
22
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
2006
Number of shared co-authors
4
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
5
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
2
Christina Curtis
Stanford University School of Medicine
Career Start Year
2004
Number of shared co-authors
4
Obi L Griffith
Washington University
Career Start Year
2003
Number of shared co-authors
4
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
1
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
4
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
12
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Peter Van Loo
The Francis Crick Institute
Career Start Year
2003
Number of shared co-authors
3
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
15
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year
2002
Number of shared co-authors
7
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
12
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year
2000
Number of shared co-authors
13
Jonathan K Killian
From Foundation Medicine
Career Start Year
1999
Number of shared co-authors
2
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year
1998
Number of shared co-authors
6
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
8
Samuel Aparicio
University of British Columbia
Career Start Year
1993
Number of shared co-authors
5
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year
1992
Number of shared co-authors
6
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
12
Matthew Meyerson
Broad Institute
Career Start Year
1983
Number of shared co-authors
14
row(s) 1 - 30 of 30
Collaborators
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
26
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers
23
Salvatore Piscuoglio
University of Basel
Co-authored papers
21
Charlotte K Y Ng
University of Bern
Co-authored papers
21
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers
12
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers
12
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers
10
David N Watkins
Research Institute in Oncology and Hematology
Co-authored papers
9
Nicola Fusco
IEO European Institute of Oncology IRCCS
Co-authored papers
8
Kathleen A Burke
Brown University
Co-authored papers
7
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers
6
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers
5
Huei-Chi Wen
Co-authored papers
4
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers
4
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers
4
Ricky W Johnstone
The University of Melbourne
Co-authored papers
4
Jason E Cain
Co-authored papers
3
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Grant A McArthur
University of Melbourne
Co-authored papers
3
Tari A King
Co-authored papers
3
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Sean M Grimmond
The University of Melbourne
Co-authored papers
3
Ronglai Shen
Co-authored papers
3
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers
3
Rita A Sakr
Universite Libre de Bruxelles
Co-authored papers
3
Alena Sk??lov??
Charles University
Co-authored papers
2
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers
2
Vanessa Tsui
Co-authored papers
2
Karel Pacak
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers
2
1 - 30